| Bruce Kaster, MD | |
|
60 Kendrick St, Ste 204, Needham, MA 02494-2726 | |
| (617) 964-8200 | |
| (617) 969-0996 |
| Full Name | Bruce Kaster |
|---|---|
| Gender | Male |
| Speciality | Geriatric Psychiatry |
| Experience | 34 Years |
| Location | 60 Kendrick St, Needham, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346281961 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0805X | Psychiatry & Neurology - Geriatric Psychiatry | 76271 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bruce A Kaster Md Pc | 6103123781 | 2 |
News Archive
Psychiatrists at Rush University Medical Center are testing a noninvasive technique that uses repeated short bursts of magnetic energy to stimulate nerve cells in the brain to treat major depression.
The Food Safety and Technology Research Centre under the Department of Applied Biology and Chemical Technology of The Hong Kong Polytechnic University has developed a new method for rapid authentication of Chinese herbal medicines, including Ganoderma (known as Lingzhi in Chinese), and Gastrodiae Rhizoma (known as Tianma in Chinese).
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing novel amino acids. Using a semi-synthetic DNA template (containing the synthetic base pair X and Y), Synthorx scientists were able to produce RNA containing X and Y, which was used with an otherwise fully natural biological system, to efficiently direct the incorporation of multiple novel amino acids at different sites in proteins.
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 on social impairment in adolescents and adults with fragile X syndrome.
› Verified 7 days ago
| Entity Name | Medoptions Of Massachusetts Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053527028 PECOS PAC ID: 2062512403 Enrollment ID: O20070713000377 |
News Archive
Psychiatrists at Rush University Medical Center are testing a noninvasive technique that uses repeated short bursts of magnetic energy to stimulate nerve cells in the brain to treat major depression.
The Food Safety and Technology Research Centre under the Department of Applied Biology and Chemical Technology of The Hong Kong Polytechnic University has developed a new method for rapid authentication of Chinese herbal medicines, including Ganoderma (known as Lingzhi in Chinese), and Gastrodiae Rhizoma (known as Tianma in Chinese).
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing novel amino acids. Using a semi-synthetic DNA template (containing the synthetic base pair X and Y), Synthorx scientists were able to produce RNA containing X and Y, which was used with an otherwise fully natural biological system, to efficiently direct the incorporation of multiple novel amino acids at different sites in proteins.
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 on social impairment in adolescents and adults with fragile X syndrome.
› Verified 7 days ago
| Entity Name | Bruce A Kaster Md Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497110738 PECOS PAC ID: 6103123781 Enrollment ID: O20160325000062 |
News Archive
Psychiatrists at Rush University Medical Center are testing a noninvasive technique that uses repeated short bursts of magnetic energy to stimulate nerve cells in the brain to treat major depression.
The Food Safety and Technology Research Centre under the Department of Applied Biology and Chemical Technology of The Hong Kong Polytechnic University has developed a new method for rapid authentication of Chinese herbal medicines, including Ganoderma (known as Lingzhi in Chinese), and Gastrodiae Rhizoma (known as Tianma in Chinese).
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing novel amino acids. Using a semi-synthetic DNA template (containing the synthetic base pair X and Y), Synthorx scientists were able to produce RNA containing X and Y, which was used with an otherwise fully natural biological system, to efficiently direct the incorporation of multiple novel amino acids at different sites in proteins.
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 on social impairment in adolescents and adults with fragile X syndrome.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bruce Kaster, MD 77 Clifton Rd, Newton, MA 02459-3111 Ph: (617) 964-8200 | Bruce Kaster, MD 60 Kendrick St, Ste 204, Needham, MA 02494-2726 Ph: (617) 964-8200 |
News Archive
Psychiatrists at Rush University Medical Center are testing a noninvasive technique that uses repeated short bursts of magnetic energy to stimulate nerve cells in the brain to treat major depression.
The Food Safety and Technology Research Centre under the Department of Applied Biology and Chemical Technology of The Hong Kong Polytechnic University has developed a new method for rapid authentication of Chinese herbal medicines, including Ganoderma (known as Lingzhi in Chinese), and Gastrodiae Rhizoma (known as Tianma in Chinese).
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19.
Synthorx Inc. announced today that the company has employed its proprietary protein expression system to successfully produce proteins containing novel amino acids. Using a semi-synthetic DNA template (containing the synthetic base pair X and Y), Synthorx scientists were able to produce RNA containing X and Y, which was used with an otherwise fully natural biological system, to efficiently direct the incorporation of multiple novel amino acids at different sites in proteins.
Seaside Therapeutics, Inc. announced today the initiation of a randomized, double-blind, placebo-controlled Phase 3 study to evaluate the effects of STX209 on social impairment in adolescents and adults with fragile X syndrome.
› Verified 7 days ago
Dr. Thor Christian Bergersen, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 75 2nd Ave, Suite 310, Needham, MA 02494 Phone: 781-726-6698 Fax: 781-726-6725 | |
Barton S Herskovitz, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 400 Hillside Ave, Needham, MA 02494 Phone: 781-449-5544 Fax: 617-714-5423 | |
Gerald H Margolis, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 232 Garden Street, Needham, MA 02492 Phone: 781-444-3837 Fax: 781-444-3837 | |
Dr. Philip D Gottlieb, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 60 Kendrick St, Ste 102, Needham, MA 02494 Phone: 617-244-3322 Fax: 617-244-1827 | |
Dr. Jonathan Noah Bass, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 91 Robinwood Ave, Needham, MA 02492 Phone: 781-449-8342 Fax: 781-449-5984 | |
John Dundas, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 20 Chestnut St, Needham, MA 02492 Phone: 781-449-0784 | |
David L Stormberg, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 105 Chestnut St, Suite 14, Needham, MA 02492 Phone: 781-449-0094 |